ADENTRA Inc. (TSX:ADEN)
Canada flag Canada · Delayed Price · Currency is CAD
33.18
+0.43 (1.31%)
May 15, 2026, 4:00 PM EST

ADENTRA Earnings Call Transcripts

Fiscal Year 2026

  • Q1 2026 saw 3.7% organic sales growth and resilient margins despite macro headwinds, with strong U.S. performance offsetting Canadian softness. Strategic focus on AI, supply chain, and disciplined M&A supports long-term value, while cost control and working capital efficiency improved leverage and cash flow.

  • AGM 2026

    The meeting confirmed quorum, elected nine directors, and reappointed KPMG LLP as auditors with strong shareholder support. No questions were received from shareholders, and final voting results will be posted on SEDAR+.

Fiscal Year 2025

  • Sales grew 3% to CAD 2.25B in 2025 with strong cash flow and margin discipline, despite softer volumes and a muted construction market. Q4 gross margin rose to 22.1%, and leverage improved to 2.2x, positioning the company for renewed M&A activity and continued shareholder returns.

  • Q3 saw 4% sales growth and stable margins despite a soft construction market, with strong cash flow and continued shareholder returns. Tariff exposure is managed via price pass-through, and further deleveraging is expected as inventory is reduced.

  • Q2 sales rose 8.7% to $597M, driven by Wolf Distributing, with gross margin and EBITDA improving year-over-year. Inventory and leverage are expected to improve in H2, while tariff exposure and trade uncertainty remain key risks.

  • Sales grew 1.4% year-over-year, driven by Wolf Distributing, while organic sales declined due to lower volumes. Gross margin held at 21.6%, adjusted EBITDA was $40M, and EPS fell to $0.42. The outlook remains cautious amid macro and trade headwinds.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Powered by